Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-9-14
|
pubmed:abstractText |
Epstein-Barr virus (EBV) has been associated with several malignant processes in man, most notably Burkitt lymphoma in previously healthy individuals and lesions resembling large cell non-Hodgkin lymphomas in organ transplant recipients. Mice with the severe combined immunodeficiency phenotype (SCID mice) are exquisitely susceptible to the development of EBV-associated lymphoproliferative lesions following the intraperitoneal (ip) inoculation of EBV-infected human lymphocytes. Recently, we reported that EBV-infected marmoset lymphocytes do not form lymphomas in SCID mice following ip injection, while human lymphocytes infected with the same EBV strains do. On the assumption that the EBV-infected marmoset cells were lacking a factor necessary for tumor formation, we transfected a plasmid containing c-myc into EBV-infected marmoset cells (B95-8, FF41, and W91 cells). Despite expression of the c-myc protein as determined by immunoblot and flow cytometry when probed with a monoclonal antibody, no increase over baseline lesion development was seen in SCID mice inoculated with 5 x 10(6) c-myc-expressing marmoset lymphoblastoid cells. Thus, cells that express c-myc and harbor EBV are not sufficient to form lymphomas in certain immunocompromised hosts.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1096-7192
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1998 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9719630-Animals,
pubmed-meshheading:9719630-Callithrix,
pubmed-meshheading:9719630-Cell Division,
pubmed-meshheading:9719630-Cell Line,
pubmed-meshheading:9719630-Cell Survival,
pubmed-meshheading:9719630-Flow Cytometry,
pubmed-meshheading:9719630-Genes, myc,
pubmed-meshheading:9719630-Herpesvirus 4, Human,
pubmed-meshheading:9719630-Immunoenzyme Techniques,
pubmed-meshheading:9719630-Killer Cells, Natural,
pubmed-meshheading:9719630-Lymphocytes,
pubmed-meshheading:9719630-Lymphoma,
pubmed-meshheading:9719630-Mice,
pubmed-meshheading:9719630-Mice, SCID,
pubmed-meshheading:9719630-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:9719630-Time Factors,
pubmed-meshheading:9719630-Transfection
|
pubmed:year |
1998
|
pubmed:articleTitle |
Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
|
pubmed:affiliation |
Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|